CLARITHYROMYCIN 250/5 Mg/Ml Granules for Oral Suspension

Valsts: Īrija

Valoda: angļu

Klimata pārmaiņas: HPRA (Health Products Regulatory Authority)

Aktīvā sastāvdaļa:

CLARITHROMYCIN

Pieejams no:

Rowex Ltd

SNN (starptautisko nepatentēto nosaukumu):

CLARITHROMYCIN

Deva:

250/5 Mg/Ml

Zāļu forma:

Granules for Oral Suspension

Receptes veids:

Product subject to prescription which may not be renewed (A)

Autorizācija statuss:

Authorised

Autorizācija datums:

0000-00-00

Lietošanas instrukcija

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT 

CLARITHROMYCIN 250 MG/5 ML GRANULES FOR ORAL SUSPENSION 

Clarithromycin 

READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS 
IMPORTANT INFORMATION FOR YOU. 
- 
Keep this leaflet. You may need to read it again. 
- 
If you have any further questions, ask your doctor
or pharmacist. 
- 
This medicine has been prescribed for you only. Do not pass it on
to others. It may harm 
them, even if their signs of illness are the same as yours. 
- 
If you get any side effects, talk to your
doctor or pharmacist. This includes any possible 
side effects not listed in this leaflet. See section 4. 

WHAT IS IN THIS LEAFLET: 
1.  What Clarithromycin is and what it is used for 
2.  What you need to know before you take Clarithromycin 
3.  How to take Clarithromycin 
4.  Possible side effects 
5.  How to store Clarithromycin 
6.  Contents of the pack and other information 

1.  WHAT CLARITHROMYCIN IS AND WHAT IT IS USED FOR 

Clarithromycin is an antibiotic which belongs to
the group of macrolide antibiotics. It stops 
the growth of certain bacteria. 

Clarithromycin is used to treat: 

  Throat and sinus infections 

  Middle ear infections in children 

  Chest infections, such as bronchitis and pneumonia 

  Skin and soft-tissue infections 

  Gastric ulcers caused by the bacterium Helicobacter pylori. 

2.  WHAT YOU NEED TO KNOW BEFORE YOU TAKE CLARITHROMYCIN  

DO NOT TAKE CLARITHROMYCIN  

  if 
y
ou are ALLERGIC to clarithromycin, other macrolide antibiotics
or to any of the other 
ingredients of this medicine
 (listed in section 6)


  if you have a history of certain abnormal HEART
RHYTHMS (ventricular arrhythmia, 
including torsades de pointes) or changes in the heart activity as
measured in the electro-
cardiogram called “QT prolong

Produkta apraksts

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Clarithromycin 250mg/5ml Granules for Oral Suspension
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
After reconstitution 1 ml oral suspension contains 50 mg clarithromycin,
5 ml oral suspension contains 250 mg clarithromycin.
Excipient with known effect:
The product contains 2.4 g sucrose per 5 ml ready- for- use suspension.
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Granules for oral suspension.
White to beige granules.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Clarithromycin 50 mg/ml granules for oral suspension is indicated in adults, adolescents and children, 6 months to 12
years, for the treatment of the following acute and chronic infections, when caused by clarithromycin susceptible
organisms.
•
Infections of the upper respiratory tract such as tonsillitis/pharyngitis, as an alternative when beta lactam
antibiotics are not appropriate.
•
Acute otitis media in children.
•
Infections of the lower respiratory tract such as community acquired pneumonia.
•
Sinusitis and acute exacerbation of chronic bronchitis in adults and adolescents over 12 years of age
•
Skin infections and soft tissue infections of mild to moderate severity.
In appropriate combination with antibacterial therapeutic regimens and an appropriate ulcer healing medicinal product
for the eradication of _Helicobacter pylori _in adult patients with _H. pylori _associated ulcers. See section 4.2.
Consideration should be given to official guidance on the appropriate use of antibacterial agents.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
The dosage of Clarithromycin 50 mg/ml granules for oral suspension depends on the clinical condition of the patient
and has to be defined in any case by the physician.
_Adults and�